ORKA Institutional Ownership
Oruka Therapeutics, Inc.
Latest close $95.84 as of Aug 5, 2026
ORKA institutional ownership at a glance
Follow Oruka Therapeutics, Inc. institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: BlackRock filed Initial Schedule 13G on Jan 21, 2026, reporting 3.2M shares and 12.00% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 accumulating across 1 comparable institution.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 3 filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Dec 31, 2025 observed Jan 21, 2026 filed · 21d Initial Schedule 13G | Initial Schedule 13G | 3.2M +978.0K | 12.00% 0.00 pts | $30.31 | $34.46 | $95.84 |
| BlackRock CIK0002012383 | Sep 30, 2025 observed Oct 17, 2025 filed · 17d Schedule 13G amendment | Earliest Schedule 13G amendment found | 2.2M | 12.00% | $19.23 | $27.48 | $95.84 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 21.6K | $95.84 |
Related research
Compare ORKA with other securities showing similar institutional activity or recent accumulation across several tracked institutions.